While theoretically reversible via glucose-6-phosphatase (G6Pase)-mediated dephosphorylation, tumor-specific G6Pase deficiency creates a metabolic trap that promotes intracellular radiotracer retention, forming the biochemical basis of 18F-FDG PET signal quantification [31]. Here, G6PC1 is linked to neoplasm.